Showing results (421-430 of 658) with videos related to
Sort By:
Pageof 66
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2024
Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized miceDong Ho Shin, Hong Jiang, Andrew G Gillard, et al.Neuro-Oncology|October 21, 2020
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymomaMark R Gilbert, Ying Yuan, Jimin Wu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 1, 2024
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic CellsHerui Wang, Rogelio Medina, Juan Ye, et al.Science Advances|October 21, 2016
TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1Mohammad B Hossain, Rehnuma Shifat, David G Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.Scientific Reports|April 28, 2022
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patientsAshish H Shah, Vaidya Govindarajan, Tara T Doucet-O'Hare, et al.Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.Neurosurgery|July 17, 2018
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype GlioblastomaDrew Pratt, Gifty Dominah, Graham Lobel, et al.Scientific Reports|July 1, 2022
Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse modelDorela D Shuboni-Mulligan, Demarrius Young, Julianie De La Cruz Minyety, et al.Pageof 66